Fighting Blindness Canada Archives - Page 4 of 6

Is Earlier Treatment Always Better? The Case for Active Monitoring.

Wednesday, August 18 2021 | 07 h 56 min | Vision Science

The importance of early diagnosis and regular treatment to prevent progression of eye diseases like glaucoma and diabetic retinopathy is often...

A Canadian Discovery Moves from the Lab to Clinical Trials

Wednesday, August 4 2021 | 07 h 44 min | Vision Science

A new potential treatment for diabetic macular edema and agerelated macular degeneration has been discovered by Canadian scientist Dr Przemyslaw...

Compete in a LIVE Event for Awards to Support Your Research!

Monday, July 12 2021 | 08 h 54 min | Awards, Contest, News, Press Release

EOTC Application_Final Fighting Blindness Canada is launching a new event, Eye on the Cure, to raise funds and awareness for...

AMD Clinical Trial Update on Next-GEN Anti-VEGF Treatment

Wednesday, June 23 2021 | 11 h 09 min | Vision Science

Roche has released the results of a Phase 3 trial of a next-generation anti-VEGF treatment, faricimab, for wet age-related macular degeneration (wet...

Paralympic Athletes Encourage Canadians to Get Active for FBC’s Cycle for Sight Virtual Event

Thursday, June 17 2021 | 11 h 52 min | Events, News, Press Release

On Saturday, June 19, Fighting Blindness Canada’s (FBC) anticipated Cycle for Sight event will once again be going virtual across...

« Previous 1 2 3 4 5 6 Next »

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

Vision Expo East 2025 will offer new conference programming for professional development in the eyecare and eyewear industry, offering over 270 hours of accredited and non-accredited education tailored to the needs of ophthalmologists, optometrists, opticians and allied professionals.

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Tag: Fighting Blindness Canada

Is Earlier Treatment Always Better? The Case for Active Monitoring.

A Canadian Discovery Moves from the Lab to Clinical Trials

Compete in a LIVE Event for Awards to Support Your Research!

AMD Clinical Trial Update on Next-GEN Anti-VEGF Treatment

Paralympic Athletes Encourage Canadians to Get Active for FBC’s Cycle for Sight Virtual Event

Featured Posts

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

NOW Trend Showcase Submission Deadline Extended to January 2025

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

NOW Trend Showcase Submission Deadline Extended to January 2025

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

NOW Trend Showcase Submission Deadline Extended to January 2025

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

NOW Trend Showcase Submission Deadline Extended to January 2025